Concourse Financial Group Securities, Inc. Bionano Genomics, Inc. Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 13, 2021	SELL	$47.0 - $155.7 $70,500 - $233,549	-1,500 Reduced 10.34%	13,000 $105,000
Q4 2020 Feb 02, 2021	SELL	$4.8 - $30.8 $33,600 - $215,600	-7,000 Reduced 32.56%	14,500 $45,000
Q3 2020 Nov 13, 2020	BUY	$4.7 - $8.9 $101,050 - $191,350	21,500 New	21,500 $14,000
Q2 2020 Aug 13, 2020	BUY	$2.6 - $5.7 $0 - $0	0 New	0 $0
Q1 2020 May 13, 2020	BUY	$3.9 - $12.7 $0 - $0	0 New	0 $0
Q4 2019 Feb 14, 2020	BUY	$5.2 - $28.5 $0 - $0	0 New	0 $0
Q3 2019 Nov 13, 2019	BUY	$6.7 - $11.8 $0 - $0	0 New	0 $0
Q2 2019 Aug 13, 2019	BUY	N/A	0 New	0 $0
Q1 2019 May 15, 2019	BUY	N/A	0 New	0 $0
Q4 2018 Feb 14, 2019	BUY	N/A	0 New	0 $0
Q3 2018 Nov 13, 2018	BUY	N/A	0 New	0 $0

Others Institutions Holding BNGO

# of Institutions

Shares Held

4.97K

Call Options Held

Put Options Held

View Full List

About Bionano Genomics, Inc.

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $58M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

More about BNGO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account